Literature DB >> 19659981

Erosive mucosal lichen planus and secondary epiphora responding to systemic cyclosporin A treatment.

Aaron E Boyce1, Gillian Marshman, Richard A D Mills.   

Abstract

Erosive mucosal lichen planus (LP) is a well-established variant of LP characterized by the formation of ulcerative lesions predominantly involving the oral and genital mucosae. Less commonly, this condition may involve oesophageal and/or ocular mucosal surfaces, and case reports within the ophthalmology literature have recently confirmed the potential for this condition to affect the nasolacrimal ducts. We report the case of a woman with severe cicatrizing mucosal LP and ocular symptoms secondary to presumed nasolacrimal duct involvement. We also report the potential for this newly appreciated manifestation of LP to respond to systemic cyclosporin A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19659981     DOI: 10.1111/j.1440-0960.2009.00536.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  4 in total

1.  Immunopathology and histopathology of conjunctival biopsies in patients with presumed idiopathic punctal stenosis.

Authors:  Amit K Reddy; Meredith S Baker; Amanda C Maltry; Nasreen A Syed; Richard C Allen
Journal:  Br J Ophthalmol       Date:  2016-04-12       Impact factor: 4.638

2.  Evaluation of ocular findings in patients with lichen planus.

Authors:  Emin Ozlu; Kuddusi Teberik
Journal:  Postepy Dermatol Alergol       Date:  2018-03-21       Impact factor: 1.837

3.  A randomized clinical trial of topical dexamethasone vs. cyclosporine treatment for oral lichen planus.

Authors:  M Georgaki; E Piperi; V-I Theofilou; E Pettas; E Stoufi; N-G Nikitakis
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-03-01

4.  Looking Beyond the Cyclosporine "Swish and Spit" Technique in a Recalcitrant Case of Erosive Lichen Planus Involving the Tongue.

Authors:  Aastha Gupta; Kabir Sardana; Ram Kishan Gautam
Journal:  Case Rep Dermatol       Date:  2017-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.